Inflection Biosciences

Irish drug developer signs licensing deal for autoimmune therapies

Inflection Biosciences chief Darren Cunningham will be head of Swiss-based Mysthera Therapeutics

Mon Aug 21 2023 - 18:45

Dublin pharma development company’s drug blocks pathways used by cancer cells

Thu Jul 18 2019 - 09:46

Inflection Biosciences working on new way to block spread of cancer cells in patients

Fri Nov 02 2018 - 05:41

Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk

Mon Apr 16 2018 - 06:39

Start-up working on way to block spread of cancer cells in patients with aggressive breast cancer

Mon Apr 16 2018 - 05:40

Inflection Biosciences seeking phase I testing for new therapy targeting aggressive cancer

Fri Apr 13 2018 - 06:02